{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T06:30:33Z","timestamp":1726381833547},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00066-023-02167-6","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T08:02:01Z","timestamp":1699862521000},"page":"377-388","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The impact of submandibular glands protection on xerostomia as monitored by diffusion-weighted imaging in nasopharyngeal carcinoma patients"],"prefix":"10.1007","volume":"200","author":[{"given":"Dawei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huayong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boning","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lujun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,13]]},"reference":[{"key":"2167_CR1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3322\/caac.21689","volume":"71","author":"K Wang","year":"2021","unstructured":"Wang\u00a0K, Tepper\u00a0JE (2021) Radiation therapy-associated toxicity: Etiology, management, and prevention. CA Cancer J Clin 71:437\u2013454. https:\/\/doi.org\/10.3322\/caac.21689","journal-title":"CA Cancer J Clin"},{"key":"2167_CR2","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/1878-0261.12750","volume":"14","author":"L Barazzuol","year":"2020","unstructured":"Barazzuol\u00a0L, Coppes\u00a0RP, van Luijk\u00a0P (2020) Prevention and treatment of radiotherapy-induced side effects. Mol Oncol 14:1538\u20131554. https:\/\/doi.org\/10.1002\/1878-0261.12750","journal-title":"Mol Oncol"},{"key":"2167_CR3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.radonc.2020.08.026","volume":"151","author":"M Dahele","year":"2020","unstructured":"Dahele\u00a0M, Tol\u00a0JP, Vergeer\u00a0MR, Jansen\u00a0F, Lissenberg-Witte\u00a0BI, Leemans\u00a0CR et al (2020) Is the introduction of more advanced radiotherapy techniques for locally-advanced head and neck cancer associated with improved quality of life and reduced symptom burden? Radiother Oncol 151:298\u2013303. https:\/\/doi.org\/10.1016\/j.radonc.2020.08.026","journal-title":"Radiother Oncol"},{"key":"2167_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.radonc.2022.07.006","volume":"175","author":"H Huang","year":"2022","unstructured":"Huang\u00a0H, Miao\u00a0J, Xiao\u00a0X, Hu\u00a0J, Zhang\u00a0G, Peng\u00a0Y et al (2022) Impact on xerostomia for nasopharyngeal carcinoma patients treated with superficial parotid lobe-sparing intensity-modulated radiation therapy (SPLS-IMRT): A\u00a0prospective phase\u00a0II randomized controlled study. Radiother Oncol 175:1\u20139. https:\/\/doi.org\/10.1016\/j.radonc.2022.07.006","journal-title":"Radiother Oncol"},{"key":"2167_CR5","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1200\/JCO.21.01208","volume":"39","author":"V Mercadante","year":"2021","unstructured":"Mercadante\u00a0V, Jensen\u00a0SB, Smith\u00a0DK, Bohlke\u00a0K, Bauman\u00a0J, Brennan\u00a0MT et\u00a0al (2021) Salivary Gland Hypofunction and\/or Xerostomia Induced by Nonsurgical Cancer Therapies:ISOO\/MASCC\/ASCO Guideline. J\u00a0Clin Oncol 39:2825\u20132843. https:\/\/doi.org\/10.1200\/JCO.21.01208","journal-title":"J Clin Oncol"},{"key":"2167_CR6","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jcms.2017.01.020","volume":"45","author":"AA Owosho","year":"2017","unstructured":"Owosho\u00a0AA, Thor\u00a0M, Oh\u00a0JH, Riaz\u00a0N, Tsai\u00a0CJ, Rosenberg\u00a0H et al (2017) The role of parotid gland irradiation in the development of severe hyposalivation (xerostomia) after intensity-modulated radiation therapy for head and neck cancer: Temporal patterns, risk factors, and testing the QUANTEC guidelines. J\u00a0Craniomaxillofac Surg 45:595\u2013600. https:\/\/doi.org\/10.1016\/j.jcms.2017.01.020","journal-title":"J Craniomaxillofac Surg"},{"key":"2167_CR7","doi-asserted-by":"publisher","unstructured":"Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, et\u00a0al. (2011) Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a\u00a0phase\u00a03 multicentre randomised controlled trial. Lancet Oncol 12:127\u201336. https:\/\/doi.org\/10.1016\/S1470-2045(10)70290\u20114","DOI":"10.1016\/S1470-2045"},{"key":"2167_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.radonc.2019.05.023","volume":"138","author":"K Sommat","year":"2019","unstructured":"Sommat\u00a0K, Hussain\u00a0A, Ong\u00a0WS, Yit\u00a0NLF, Khoo\u00a0JBK, Soong\u00a0YL et\u00a0al (2019) Clinical and dosimetric predictors of physician and patient reported xerostomia following intensity modulated radiotherapy for nasopharyngeal cancer\u2014A prospective cohort analysis. Radiother Oncol 138:149\u2013157. https:\/\/doi.org\/10.1016\/j.radonc.2019.05.023","journal-title":"Radiother Oncol"},{"key":"2167_CR9","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.ijrobp.2011.09.004","volume":"83","author":"M Little","year":"2012","unstructured":"Little\u00a0M, Schipper\u00a0M, Feng\u00a0FY, Vineberg\u00a0K, Cornwall\u00a0C, Murdoch-Kinch\u00a0CA et al (2012) Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands. Int J Radiat Oncol Biol Phys 83:1007\u20131014. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.09.004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2167_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.radonc.2017.08.002","volume":"126","author":"PG Hawkins","year":"2018","unstructured":"Hawkins\u00a0PG, Lee\u00a0JY, Mao\u00a0Y, Li\u00a0P, Green\u00a0M, Worden\u00a0FP et al (2018) Sparing all salivary glands with IMRT for head and neck cancer: Longitudinal study of patient-reported xerostomia and head-and-neck quality of life. Radiother Oncol 126:68\u201374. https:\/\/doi.org\/10.1016\/j.radonc.2017.08.002","journal-title":"Radiother Oncol"},{"key":"2167_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.oraloncology.2018.12.021","volume":"89","author":"V Varra","year":"2019","unstructured":"Varra\u00a0V, Ross\u00a0RB, Juloori\u00a0A, Campbell\u00a0S, Tom\u00a0MC, Joshi\u00a0NP et\u00a0al (2019) Selectively sparing the submandibular gland when level Ib lymph nodes are included in the radiation target volume: An initial safety analysis of a\u00a0novel planning objective. Oral Oncol 89:79\u201383. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.12.021","journal-title":"Oral Oncol"},{"key":"2167_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13014-017-0869-x","volume":"12","author":"X Ou","year":"2017","unstructured":"Ou\u00a0X, Miao\u00a0Y, Wang\u00a0X, Ding\u00a0J, He\u00a0X, Hu\u00a0C (2017) The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low-risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck nodal levels. Radiat Oncol 12:137. https:\/\/doi.org\/10.1186\/s13014-017-0869-x","journal-title":"Radiat Oncol"},{"key":"2167_CR13","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ijrobp.2021.05.114","volume":"111","author":"L Van den Bosch","year":"2021","unstructured":"Van den Bosch\u00a0L, van der Laan\u00a0HP, van der Schaaf\u00a0A, Oosting\u00a0SF, Halmos\u00a0GB, Witjes\u00a0MJH et al (2021) Patient-Reported Toxicity and Quality-of-Life Profiles in Patients With Head and Neck Cancer Treated With Definitive Radiation Therapy or Chemoradiation. Int J Radiat Oncol Biol Phys 111:456\u2013467. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.05.114","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2167_CR14","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1001\/jamaoto.2022.1495","volume":"148","author":"SM Long","year":"2022","unstructured":"Long\u00a0SM, Singh\u00a0A, Tin\u00a0AL, O\u2019Hara\u00a0B, Cohen\u00a0MA, Lee\u00a0N et al (2022) Comparison of Objective Measures of Trismus and Salivation With Patient-Reported Outcomes Following Treatment for Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg 148:749\u2013755. https:\/\/doi.org\/10.1001\/jamaoto.2022.1495","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2167_CR15","doi-asserted-by":"publisher","first-page":"105783","DOI":"10.1016\/j.oraloncology.2022.105783","volume":"127","author":"A Lin","year":"2022","unstructured":"Lin\u00a0A, Helgeson\u00a0ES, Treister\u00a0NS, Schmidt\u00a0BL, Patton\u00a0LL, Elting\u00a0LS et\u00a0al (2022) The impact of head and neck radiotherapy on salivary flow and quality of life: Results of the ORARAD study. Oral Oncol 127:105783. https:\/\/doi.org\/10.1016\/j.oraloncology.2022.105783","journal-title":"Oral Oncol"},{"key":"2167_CR16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ijrobp.2021.09.023","volume":"112","author":"R Steenbakkers","year":"2022","unstructured":"Steenbakkers\u00a0R, van Rijn-Dekker\u00a0MI, Stokman\u00a0MA, Kierkels\u00a0RGJ, van der Schaaf\u00a0A, van den Hoek\u00a0JGM et al (2022) Parotid Gland Stem Cell Sparing Radiation Therapy for Patients With Head and Neck Cancer: A\u00a0Double-Blind Randomized Controlled Trial. Int J Radiat Oncol Biol Phys 112:306\u2013316. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.09.023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2167_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.radonc.2016.07.008","volume":"122","author":"V Loimu","year":"2017","unstructured":"Loimu\u00a0V, Seppala\u00a0T, Kapanen\u00a0M, Tuomikoski\u00a0L, Nurmi\u00a0H, Makitie\u00a0A et al (2017) Diffusion-weighted magnetic resonance imaging for evaluation of salivary gland function in head and neck cancer patients treated with intensity-modulated radiotherapy. Radiother Oncol 122:178\u2013184. https:\/\/doi.org\/10.1016\/j.radonc.2016.07.008","journal-title":"Radiother Oncol"},{"key":"2167_CR18","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s00066-020-01580-5","volume":"196","author":"WJ Fan","year":"2020","unstructured":"Fan\u00a0WJ, Teng\u00a0F, Luo\u00a0YR, Yu\u00a0W, Zhang\u00a0Q, Lu\u00a0YP et al (2020) Diffusion-weighted imaging as a\u00a0follow-up modality for evaluation of major salivary gland function in nasopharyngeal carcinoma patients: a\u00a0preliminary study. Strahlenther Onkol 196:530\u2013541. https:\/\/doi.org\/10.1007\/s00066-020-01580-5","journal-title":"Strahlenther Onkol"},{"key":"2167_CR19","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s12903-019-0951-x","volume":"19","author":"D Shi","year":"2019","unstructured":"Shi\u00a0D, Qian\u00a0JJ, Fan\u00a0GH, Shen\u00a0JK, Tian\u00a0Y, Xu\u00a0L (2019) Salivary gland function in nasopharyngeal carcinoma before and late after intensity-modulated radiotherapy evaluated by dynamic diffusion-weighted MR imaging with gustatory stimulation. Bmc Oral Health 19:288. https:\/\/doi.org\/10.1186\/s12903-019-0951-x","journal-title":"Bmc Oral Health"},{"key":"2167_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.brainresbull.2018.01.015","volume":"139","author":"A Arab","year":"2018","unstructured":"Arab\u00a0A, Wojna-Pelczar\u00a0A, Khairnar\u00a0A, Szabo\u00a0N, Ruda-Kucerova\u00a0J (2018) Principles of diffusion kurtosis imaging and its role in early diagnosis of neurodegenerative disorders. Brain Res Bull 139:91\u201398. https:\/\/doi.org\/10.1016\/j.brainresbull.2018.01.015","journal-title":"Brain Res Bull"},{"key":"2167_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.radonc.2022.05.011","volume":"172","author":"DW Zhao","year":"2022","unstructured":"Zhao\u00a0DW, Fan\u00a0WJ, Fang\u00a0XM, Luo\u00a0YR, Wei\u00a0J, Chen\u00a0NX et\u00a0al (2022) Sparing submandibular gland to alleviating acute xerostomia in patients with nasopharyngeal carcinoma treated with helical tomotherapy: Evaluation by diffusion kurtosis imaging. Radiother Oncol 172:91\u201398. https:\/\/doi.org\/10.1016\/j.radonc.2022.05.011","journal-title":"Radiother Oncol"},{"key":"2167_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.radonc.2021.02.004","volume":"157","author":"WJ Fan","year":"2021","unstructured":"Fan\u00a0WJ, Teng\u00a0F, Liu\u00a0G, Zhao\u00a0DW, Li\u00a0JF, Luo\u00a0YR et\u00a0al (2021) Diffusion weighted imaging in submandibular gland sparing helical tomotherapy for nasopharyngeal carcinoma. Radiother Oncol 157:247\u2013254. https:\/\/doi.org\/10.1016\/j.radonc.2021.02.004","journal-title":"Radiother Oncol"},{"key":"2167_CR23","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00015.2021","author":"AM Chibly","year":"2022","unstructured":"Chibly\u00a0AM, Aure\u00a0MH, Patel\u00a0VN, Hoffman\u00a0MP (2022) Salivary Gland Function, Development and Regeneration. Physiol Rev. https:\/\/doi.org\/10.1152\/physrev.00015.2021","journal-title":"Physiol Rev"},{"key":"2167_CR24","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1177\/0022034509343143","volume":"88","author":"O Grundmann","year":"2009","unstructured":"Grundmann\u00a0O, Mitchell\u00a0GC, Limesand\u00a0KH (2009) Sensitivity of salivary glands to radiation: from animal models to therapies. J\u00a0Dent Res 88:894\u2013903. https:\/\/doi.org\/10.1177\/0022034509343143","journal-title":"J Dent Res"},{"key":"2167_CR25","doi-asserted-by":"publisher","first-page":"7802334","DOI":"10.1155\/2022\/7802334","volume":"2022","author":"Y Li","year":"2022","unstructured":"Li\u00a0Y, Li\u00a0X, Pang\u00a0R, Yang\u00a0G, Tian\u00a0M, Zhao\u00a0T et al (2022) Diagnosis, Prevention, and Treatment of Radiotherapy-Induced Xerostomia: A\u00a0Review. J\u00a0Oncol 2022:7802334. https:\/\/doi.org\/10.1155\/2022\/7802334","journal-title":"J Oncol"},{"key":"2167_CR26","doi-asserted-by":"publisher","unstructured":"van Luijk P, Pringle S, Deasy JO, Moiseenko VV, Faber H, Hovan A, et\u00a0al. (2015) Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer. Sci Transl Med 7:305ra147. https:\/\/doi.org\/10.1126\/scitranslmed.aac4441","DOI":"10.1126\/scitranslmed.aac4441"},{"key":"2167_CR27","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3348\/kjr.2018.19.2.328","volume":"19","author":"Q Zhang","year":"2018","unstructured":"Zhang\u00a0Q, Wei\u00a0YM, Qi\u00a0YG, Li\u00a0BS (2018) Early Changes in Apparent Diffusion Coefficient for Salivary Glands during Radiotherapy for Nasopharyngeal Carcinoma Associated with Xerostomia. Korean J Radiol 19:328\u2013333. https:\/\/doi.org\/10.3348\/kjr.2018.19.2.328","journal-title":"Korean J Radiol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-023-02167-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-023-02167-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-023-02167-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T11:02:24Z","timestamp":1713870144000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-023-02167-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,13]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["2167"],"URL":"https:\/\/doi.org\/10.1007\/s00066-023-02167-6","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,13]]},"assertion":[{"value":"7 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"D.\u00a0Zhao, W.\u00a0Fan, H.\u00a0Jiang, L.\u00a0Meng, B.\u00a0Cai, X.\u00a0Zhang, W.\u00a0Yu, L.\u00a0Zhao and L.\u00a0Ma declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. This study (Clinical Trial Registry number: ChiCTR1900024328) was approved by the research ethics board of the Chinese PLA General Hospital. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}